title: Activation of lung vagal sensory receptors by circulatory endotoxin in rats.
abstract: Although endotoxin is known to induce various pulmonary responses that are linked to the function of lung vagal sensory receptors, its effects on these pulmonary receptors are still not clear. This study investigated the effects of circulatory endotoxin on the afferent activity of lung vagal sensory receptors in rats. We recorded afferent activity arising from vagal pulmonary C fibers (CFs), rapidly adapting receptors (RARs), tonic pulmonary stretch receptors (T-PSRs), and phasic pulmonary stretch receptors (P-PSRs) in 64 anesthetized, paralyzed, and artificially ventilated rats. Intravenous injection of endotoxin (50 mg/kg; lipopolysaccharide) stimulated 7 of the 8 CFs, 8 of the 8 RARs, and 4 of the 8 T-PSRs studied, while having no effect on the 8 P-PSRs tested. The stimulation started 3-16 min after endotoxin injection and lasted until the end of the 90-min observation period. The evoked discharge of either CFs or RARs was not in phase with the ventilatory cycle, whereas that of T-PSRs showed a respiratory modulation. Injection of a saline vehicle caused no significant change in the discharge of these receptors. Additionally, endotoxin significantly produced an increase in total lung resistance, and decreases in dynamic lung compliance and arterial blood pressure. Our results demonstrate that a majority of lung vagal sensory receptors are activated following intravenous injection of endotoxin, and support the notion that these pulmonary receptors may function as an important afferent system during endotoxemia.
authors: Institute of Physiology, School of Medicine and Life Science, National Yang-Ming University, Taipei, Taiwan.
authors: Ching Jung
authors: CJ
authors: Lai
authors: Ching-Yin
authors: CY
authors: Ho
authors: Yu Ru
authors: YR
authors: Kou
mesh_terms: D000200:Action Potentials; D000344:Afferent Pathways / Q000187:drug effects / Q000503:physiopathology; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D006985:Hyperventilation / Q000503:physiopathology; D007275:Injections, Intravenous; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000494:pharmacology*; D008168:Lung / Q000187:drug effects* / Q000294:innervation; D008297:Male; D009412:Nerve Fibers / Q000187:drug effects / Q000502:physiology; D011661:Pulmonary Stretch Receptors / Q000187:drug effects* / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014630:Vagus Nerve / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D008070:Lipopolysaccharides; D002211:Capsaicin